Philip has more than 20 years' experience writing about companies, general finance and investing matters for a variety of publications. His career has involved spells at the Investors Chronicle, where he was small companies and companies editor, Investors Week and most recently as editor of online financial news wire Sharecast. He has also contributed to a wide range of financial-focused publications on a freelance basis.
The Qataris want to buy at least US$808mln worth of its shares said the airline
Originally a 1,000km 3D survey was planned but Eco and partner Tullow Oil have now agreed to increase this to the entire block area, or 2,550km
Protagonist will receive an upfront payment of US$50mln from Janssen with milestones, royalties and other sales milestones worth up to a further US$940mln.
The Zimbabwe-focused gold miner is to consolidate its shares on a 5 for one basis.
Summit wants to improve absorption of ezutromid in patients with duchenne muscular dystrophy (DMD) through a modified diet and new formulation.
Net income was up 14% to US$3.23bn, or 76 cents a share,
Over 1,000 plaintiffs have sued J&J in the state of Missouri but most are from outside of the state.
Rubraca is one of a new type of cancer treatment called PARP-inhibitors